August 20, 2025 records indicate that Representative Thomas Kean filed a sale of Johnson & Johnson (NYSE:JNJ), valued between $31,003 and $115,000. According to the August filing, the transaction occurred on July 31, 2025.
Currently, Johnson & Johnson shares are trading up 0.16% at $179.13.
What Representative Has Been Trading Recently
Over the past three years, Thomas Kean executed 105 trades totaling over $427 thousand. The largest of these trades were in Aon and Johnson & Johnson stock. Some of the key transactions the Rep. has executed recently include:
- Johnson & Johnson (NYSE:JNJ): $15,001 - $50,000 Purchase
- Stryker (NYSE:SYK): $15,001 - $50,000 Purchase
- Check Point Software (NASDAQ:CHKP): $15,001 - $50,000 Purchase
Here is a list of Thomas Kean's most recent trades:
| Company | Ticker | Stock Type | Amount | Transaction Type | Transaction Date |
|---|---|---|---|---|---|
| Johnson & Johnson | JNJ | STOCK | $15,001 - $50,000 | S (Partial) | 2025-07-31 |
| Stryker | SYK | STOCK | $15,001 - $50,000 | S (Partial) | 2025-07-31 |
| Adobe | ADBE | STOCK | $1,001 - $15,000 | S | 2025-07-29 |
| Check Point Software | CHKP | STOCK | $15,001 - $50,000 | P | 2025-07-29 |
| Abbott Laboratories | ABT | STOCK | $1,001 - $15,000 | P | 2025-07-21 |
Stay informed on Thomas Kean's trades and other members of Congress with our real-time government trades tracking tool!
Why Congressional Transactions Matter
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
Why Congressional Transactions Matter
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
